Management of chronic heart failure due to systolic left ventricular dysfunction by cardiologist and non-cardiologist physicians.
- 11 August 2003
- journal article
- Published by Wiley in European Journal of Heart Failure
- Vol. 5 (4) , 549-555
- https://doi.org/10.1016/s1388-9842(03)00003-5
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Randomized, controlled trial of integrated heart failure management. The Auckland Heart Failure Management StudyEuropean Heart Journal, 2002
- A Randomized Trial of the Angiotensin-Receptor Blocker Valsartan in Chronic Heart FailureNew England Journal of Medicine, 2001
- Specialty-related differences in the epidemiology, clinical profile, management and outcome of patients hospitalized for heart failure. The OSCUR studyEuropean Heart Journal, 2001
- Serious adverse events experienced by patients with chronic heart failure taking spironolactoneHeart, 2001
- Trends in hospitalization for heart failure in Scotland, 1990–1996. An epidemic that has reached its peak?European Heart Journal, 2001
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trialThe Lancet, 1999
- The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart FailureNew England Journal of Medicine, 1996
- Physical training improves skeletal muscle metabolism in patients with chronic heart failureJournal of the American College of Cardiology, 1993
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987